Larimar Therapeutics (LRMR) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.42
-0.33
-0.24
-0.15

Details

Expected EPS
-0.19
Actual EPS
-0.19
Surprise EPS
0
Surprise Percent
+0%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.19 per share for Q2 2023.

0 Comments

Share your thoughts